U.S. Markets open in 15 hrs, 16 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 2.00 09:30 AM EST | |
|---|---|---|
| Day High | 2.15 09:39 AM EST |
|
| Range | 0.15 |
| Volume | 249,908 | |
|---|---|---|
| 30-Day Avg Vol | 530,000 |
|
| Difference | -52.85% |
| Market Cap | 78.35 M | |
|---|---|---|
| Mkt Cap Chg | 373,099 |
| Shares Out | 37.30 M | |
|---|---|---|
| % Shrs Traded | 0.67% | |
| 1yr EPS Est | -0.802 |
| 52-Wk Low | 1.44 | |
|---|---|---|
| 52-Wk High | 8.43 |
|
| Range | 6.99 |
| Prev Close | 2.09 11/6/09 | |
|---|---|---|
| Today's Open | 2.08 | |
| Change | -0.48% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.44 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -32.40 M | |
| Earnings (MRQ) | -7.73 M | |
| Next Earn Est | -0.205 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | -1.01 | |
| 1yr EPS Growth | 21.37% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -2.00 | |
| PEG Ratio | — | |
| Return on Equity | -79.68 | |
| Beta | -0.81 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Anadys Pharmaceuticals has hepatitis and cancer in the crosshairs. The biotechnology company is developing new therapeutic treatments for those infected with hepatitis C (HCV) and other bacterial infections, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.205 2/22/10 | — — |
—
—
|
| Last Quarter | -0.203 9/30/09 | -0.21 9/30/09 |
-0.007
Missed
|
| 2 Quarters Ago | -0.28 6/30/09 | -0.21 6/30/09 |
0.07
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | -276,000.00 | -1.14 M |
| Operating Income | -6.05 M | -34.10 M |
| Net Income | -7.73 M | -32.40 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts